FDA warns against use of Pfizer's Revatio in children

Administrator 60 Reuters Health
Print Email

(Reuters) - U.S. health regulators recommended against use of Pfizer Inc's pulmonary arterial hypertension (PAH) drug Revatio in children up to 17 years of age, saying it had a higher risk of death when taken in a high dose.

Read Full Article


You can contact us at: